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trometry (MALDI-TOF MS) has been widely used in microbial identification. This study evalu-
ated the performance of MALDI-TOF MS and investigated the economic and medical impact
of MALDI-TOF MS implementation.
Methods: A total of 12,202 clinical isolates collected from April to September 2013 were iden-
tified using MALDI-TOF MS, and the success rates in identifying isolates were analyzed. The dif-
ferences in the processing time, cost of consumables, weight of waste, and clinical impact
between MALDI-TOF MS and biochemical reaction were compared.
Results: MALDI-TOF MS successfully identified 96% of 12,202 isolates, including 96.8% of 10,502
aerobes, 90.5% of 1481 anaerobes, 93.8% of 81 yeasts, and 90.6% of 138 nontuberculous myco-
bacteria at the genus level. By using MALDI-TOF MS, the processing time for aerobes decreased
from 32.5 hours to 4.1 hours, and that for anaerobes decreased from 71.5 hours to 46 hours.t of Laboratory Medicine, Chang Gung Memorial Hospital at Linkou, 5, Fu-Hsing Street, Kueishan 333,
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Infection (2016), http://dx.doi.org/1For detection of aerobes and anaerobes, the cost of consumables was estimated to decrease
by US$0.9 per isolate, thus saving US$94,500 in total annual isolation. Furthermore, the weight
of waste decreased six-fold, resulting in a reduction of 350 kg/month or 4.2 tons/year. MALDI-
TOF MS also increased the percentage of correct antibiotics treatment for Escherichia coli and
Klebsiella pneumonia from 56.1% to 75% and shortened the initiation time of the correct anti-
biotic action from 3.3 hours to 2.5 hours.
Conclusions: MALDI-TOF MS is a rapid, reliable, economical, and environmentally friendly
method for routine microbial identification and may contribute to early appropriate antibiotic
treatment in clinical settings.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
The conventional methods for identifying microorganisms in
clinical microbiology laboratories are based on biochemical
methods and gene sequencing identification techniques.
However, these procedures take considerable time, and the
results may be difficult to interpret occasionally because of
indistinct reactions or outdated databases.1,2 Recently,
matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) has been effectively
used as a rapid method for identifying a wide array of mi-
crobial species.3,4 In MALDI-TOF MS analysis, abundant
structural proteins such as ribosomal proteins are extracted
from an intact bacterial colony. The ionizing laser vaporizes
the abundant structural proteins of microorganisms, and
unique mass spectra are generated, having mass-to-charge
ratio (m/z) peaks with varying intensities. The mass spectra
of test isolates are sequentially compared with those in a
reference database for identification. Unknown organisms
can be identified by matching the organism’s spectrum to
the most similar spectrum in the database. Depending on
the MALDI-TOF MS score, the genus and species identifica-
tion for an organism may be accurate.
MALDI-TOF MS can provide advantages for a universal
procedure of microbial identification. Only a small amount
of an organism, typically a fraction of a single colony from
primary culture plates, is required for analysis. Compara-
tively, a larger inoculum and subculture is often required
for conventional biochemical methods or other automated
systems. The differences in procedure time and cost per
isolate between MALDI-TOF MS and biochemical identifica-
tion have been shown in previous studies.1,5 However, cost
assessment related to the subcultures required for the
biochemical method, secondary biochemical testing such as
coagulase for staphylococci, and the annual maintenance
cost of MALDI-TOF MS should be considered when imple-
menting MALDI-TOF MS in clinical settings. Furthermore,
biohazard waste generated daily from microbial cultures
and laboratory analysis may affect human health, waste
management costs, and the environment. Because of its
relative simplicity and speed, MALDI-TOF MS enables
reducing the time spent on microbial identification. Rapid
identification of microorganisms may contribute to the
early treatment of patients by using an appropriate anti-
microbial therapy, thereby improving patient outcomes,M-C, et al., Routine identificatio
uccess rate, economic analysis,
0.1016/j.jmii.2016.06.002reducing the potential for microorganisms to develop
antimicrobial resistance, and lowering mortality among
bacteremic patients with sepsis.6e8
Although the use of MALDI-TOF MS for microbial identifi-
cation has been well established,9,10 its performance in
identifying success rates and scores among different micro-
bial species has yet to be extensively evaluated in clinical
practice by using numerous clinical isolates. In addition, evi-
dence of the impact of MALDI-TOF MS on costs, waste reduc-
tion, and the clinical outcomes of patients remains limited. In
April 2013, the laboratory at Linkou Chang Gung Memorial
Hospital switched from the conventional biochemicalmethod
to MALDI-TOF MS for microbial identification. Over a 6-month
period, we evaluated the success rate of MALDI-TOF MS in
identifying clinically relevant microorganisms, including aer-
obic and anaerobic bacteria, yeasts, and nontuberculous
mycobacteria (NTM), at a 4000-bed tertiary teaching hospital
(Linkou Chang Gung Memorial Hospital). In addition, we
compared the processing time, cost of consumables, weight
of waste, and clinical outcome of microbial identification
between MALDI-TOF MS and biochemical methods.
Materials and methods
Microorganism isolates
A total of 12,202 clinical isolates, comprising aerobes
(n Z 10,502), anaerobes (n Z 1481), yeasts (n Z 81), and
NTM (n Z 138), were included in this study. The clinical
isolates were obtained from fresh clinical specimens at
Linkou Chang Gung Memorial Hospital in Taiwan from April
to September 2013.
Sample preparation and MALDI-TOF MS analysis
The microorganism identifications and data analyses were
performed using the Bruker LT microflex MALDI-TOF mass
spectrometer (Bruker Daltonics, Bremen, Germany). Sam-
ple preparation methods for MALDI-TOF MS analysis were
performed as recommended by the manufacturer’s proto-
col. A direct smear method with a 70% formic acid overlay
was used for preparing aerobic and anaerobic bacteria
samples, and ethanoleformic acid extraction and silica
bead-based extraction methods were performed forn of microorganisms by matrix-assisted laser desorption ionization
and clinical outcome, Journal of Microbiology, Immunology and
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were analyzed using the MALDI Biotyper automation control
and Bruker Biotyper 3.0 system software (Bruker Daltonics).
The MALDI-TOF mass spectrum database used comprised
4613 reference microorganism spectra (4274 bacteria, 332
eukaryotes, and 7 archaea). Scores  2.0 were considered
reliable for identifying bacteria at the species level, and
scores  1.7 and < 2.0 were considered reliable for iden-
tifying those at the genus level. Scores < 1.7 indicated
ambiguous identification, and such identifications were
confirmed according to the Clinical and Laboratory Stan-
dards Institute standard method. Failure to obtain signals
by using mass spectrometry was designated no peaks found,
and failure to match a spectrum to a spectrum in the
database designated no reliable identification.
Time to identification
All positive results of aerobic or anaerobic bacteria iden-
tified using the biochemical method in December 2012 or
using MALDI-TOF MS in July 2013 were calculated. Culture
time was defined as the time from specimen collection to
the occurrence of a colony size large enough for identifi-
cation. Time to identification is defined as the time from
colony formation to the time at which the final result re-
ported to a physician is obtained.
Costs
The costs of the biochemical method may vary slightly,
depending on the individual microbial species to be identi-
fied. Because aerobic and anaerobic bacteria were the most
frequently isolated in clinical samples, we estimated the
average costs of 52,500 isolates (47,200 aerobic and 5300
anaerobic isolates), including the costs for culture media,
reagents, and biochemical testing, from July to December
2012. The average costs per isolate (US$1.6) for the
biochemicalmethodwas calculated by dividing the total cost
(US$84,000) by the total number of isolates (nZ 52,500). The
cost (US$0.7) of using MALDI-TOF MS for identification
included the cost of the a-cyano-4-hydroxycinnamic acid
matrix, ion detector, laser, and protein standard.
Weight of biohazard waste
The biohazard waste generated using the biochemical
method and MALDI-TOF MS was weighed daily in December
2012 and July 2013, respectively, and the data were used to
estimate the weight of monthly biohazard waste.
Clinical features and outcomes of patients
All hospitalized patients older than 18 years with bacterial
cultures positive for Escherichia coli or Klebsiella pneumo-
niae from October to December 2012 were included and
compared with patients whose bacteria samples were iden-
tifiedusingMALDI-TOFMS in the sameperiod in 2013.Patients
with infections before hospital admission were excluded
from the study. The numbers of days of hospitalization and
mortality rates of all patients were collected and compared
between the two patient groups. The time to antibioticsPlease cite this article in press as: Ge M-C, et al., Routine identificatio
time-of-flight mass spectrometry: Success rate, economic analysis,
Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.06.002refers to the time from specimen collection to appropriate
antibiotic administration, and antibiotic treatments that
matched the drug susceptibility patterns of bacteria isolates
were designated correct antibiotic treatments.Results
MALDI-TOF MS identification rates for aerobic and
anaerobic bacteria
Table 1 shows a ranked list of aerobic and anaerobic bac-
teria reported during one 6 months of 2013. Of the 10,502
aerobic bacteria, 96.8% (10,170/10,502) of isolates were
identified at the genus level (2.0 > score  1.7), and 88.7%
(9316/10,502) of isolates were identified at the species
level (score  2.0) by using MALDI-TOF MS. Among the top
10 aerobic bacteria accounting for 67.7% of all isolates, the
estimated identification success rates achieved using this
method were 91.2% to 100% at the genus level and 78.8% to
99.3% at the species level. By using MALDI-TOF MS, high
rates of species identification were achieved for aerobic
Gram-negative bacteria, such as E. coli (94.7%), K. pneu-
monia (92.1%), Pseudomonas aeruginosa (97.5%), and Pro-
teus mirabilis (99.0%), and Gram-positive bacteria, such as
Enterococcus faecalis (99.3%), Staphylococcus aureus
(98.2%), and Streptococcus agalactiae (99.2%).
MALDI-TOF MS failed to identify 3.2% (332/10,502) of
aerobic bacteria. Among these, the failure to identify 4.5%
(n Z 42) of K. pneumonia and 1.7% (n Z 29) of E. coli was
mainly due to the absence of peaks. In addition, the failure
to identify 3.9% (n Z 36) of Coag () Staphylococcus, 8.8%
(n Z 29) of Viridans streptococcus, and 3.7% (n Z 22) of
Acinetobacter baumannii was mainly attributed to a lack of
reliable identification. No considerable difference was
evident between the Gram-negative and Gram-positive
bacteria in success rates (96.8% vs. 97.2%).
MALDI-TOF MS also successfully identified 90.5% (1341/
1481) and 78.5% (1163/1481) of anaerobic bacteria at the
genus and species levels, respectively. These rates are lower
than those for aerobic bacteria at both levels. The eightmost
common anaerobic bacteria accounted for 56% of total iso-
lates and were estimated in the range of 55.1% to 100% at the
genus level and 51.4% to 93.3% at the species level. The
highest success rates at both the species (93.3%) and genus
levels (100%) were those for Bacteroides thetaiotaomicron.
However, the lowest success rate at the species and genus
levelswas that forPeptostreptococcus spp. (51.4% for species
and 55.1% for genus), followed by Prevotella spp. (73.6% and
81.7%), resulting in 44.9% (nZ 48) ofPeptostreptococcus spp.
and 18.3% (nZ 36) of Prevotella spp. remaining unidentified.
Identification failure was attributed primarily to the absence
of reliable identification profiles. The overall failure rate in
anaerobic bacteria identification was 9.5% (nZ 140).
MALDI-TOF MS identification rates in yeasts and
NTM
As shown in Table 2, the total success rates of species and
genus identification for yeast by using MALDI-TOF MS were
77.8% (63/81) and 93.8% (76/81), respectively. Notably, then of microorganisms by matrix-assisted laser desorption ionization
and clinical outcome, Journal of Microbiology, Immunology and
Table 1 Routine identification performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
for aerobic and anaerobic bacteria.
Microorganism Total no. No. (%) of isolates
identified to
No. (%) of unidentified isolates
Species level Genus level Total No peaks found No reliable identification
Aerobes 10502 9316 (88.7) 10170 (96.8) 332 (3.2) 143 (1.4) 189 (1.8)
Gram-negative 6861 6130 (89.3) 6632 (96.7) 229 (3.3) 116 (1.7) 113 (1.6)
Escherichia coli 1671 1582 (94.7) 1642 (98.3) 29 (1.7) 25 (1.5) 4 (0.2)
Klebsiella pneumoniae 931 857 (92.1) 889 (95.5) 42 (4.5) 41 (4.4) 1 (0.1)
Pseudomonas aeruginosa 757 738 (97.5) 747 (98.7) 10 (1.3) 4 (0.5) 6 (0.8)
Acinetobacter baumannii 590 516 (87.5) 568 (96.3) 22 (3.7) 5 (0.8) 17 (2.9)
Proteus mirabilis 310 307 (99.0) 310 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Others 2602 2130 (81.9) 2476 (95.2) 126 (4.8) 41 (1.5) 85 (3.3)
Gram-positive 3641 3186 (87.5) 3538 (97.2) 103 (2.8) 27 (0.7) 76 (2.1)
Coag () Staphylococcus 935 749 (80.1) 899 (96.1) 36 (3.9) 6 (0.6) 30 (3.2)
Staphylococcus aureus 613 602 (98.2) 611 (99.7) 2 (0.3) 0 (0.0) 2 (0.3)
Enterococcus faecalis 579 575 (99.3) 579 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Streptococcus agalactiae 389 386 (99.2) 388 (99.7) 1 (0.3) 1 (0.3) 0 (0.0)
Viridans streptococcus 330 260 (78.8) 301 (91.2) 29 (8.8) 9 (2.7) 20 (6.1)
Others 795 614 (77.2) 760 (95.6) 35 (4.4) 11 (1.4) 24 (3.0)
Anaerobes 1481 1163 (78.5) 1341 (90.5) 140 (9.5) 43 (2.9) 97 (6.5)
Gram-negative 903 751 (83.2) 845 (93.6) 58 (6.4) 18 (2.0) 40 (4.4)
Bacteriodes fragilis 215 200 (93.0) 213 (99.1) 2 (0.9) 0 (0.0) 2 (0.9)
Prevotella spp. 197 145 (73.6) 161 (81.7) 36 (18.3) 11 (5.6) 25 (12.7)
Veillonella spp. 63 52 (82.5) 59 (93.7) 4 (6.3) 0 (0.0) 4 (6.3)
Bacteroides thetaiotaomicron 60 56 (93.3) 60 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Others 368 298 (81.0) 352 (95.7) 16(4.3) 7 (1.9) 9 (2.4)
Gram-positive 578 412 (71.3) 496 (85.8) 82 (14.2) 25 (4.3) 57 (9.9)
Peptostreptococcus spp. 107 55 (51.4) 59 (55.1) 48 (44.9) 13 (12.1) 35 (32.7)
Propionibacterium acnes 84 65 (77.4) 76 (90.5) 8 (9.5) 6 (7.1) 2 (2.4)
Peptostreptococcus micros 62 56 (90.3) 62 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Peptostreptococcus anaerobius 42 37 (88.1) 38 (90.5) 4 (9.5) 1 (2.4) 3 (7.1)
Others 283 199 (70.3) 261 (92.2) 22 (7.8) 5 (1.8) 17 (6.0)
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+ MODELsuccess rates for Candida glabrata reached 100% at both
the species and genus levels. However, the genus identifi-
cation rate for Candida parapsilosis was only 85.7%, and no
peaks were determined in the corresponding MALDI-TOF MS
results of two unidentified isolates. These results showed
that the success rates of yeast identification were highly
dependent on the yeast species.
MALDI-TOF MS was used to analyze 138 NTM isolates. The
success rates for the rapid- and slow-growing types were
slightly different (Table 2). The slow-growing types had a
higher genus identification rate (92.2%) than that of the
rapid-growing types (87.5%), but their species identification
rate (68.8%) was lower than that of the rapid-growing types
(87.5%). The MALDI-TOF MS analysis of unidentified isolates
indicated that no peaks were found in the slow-growing
type, and failure to identify isolates of the rapid-growing
type was mainly due to a lack of reliable identification.Comparisons of time to identification, cost, and
biohazard weight between biochemical and MALDI-
TOF MS identification
To ascertain the differences in the time of microbial iden-
tification, the processing times for aerobic and anaerobicPlease cite this article in press as: Ge M-C, et al., Routine identificatio
time-of-flight mass spectrometry: Success rate, economic analysis,
Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.06.002bacteria identification were evaluated first (Table 3). The
culture time required for bacterial colony formation (from
sample receipt to colony formation) was similar for the two
methods. Time to identification (from colony formation to
complete bacterial identification) was markedly lower for
MALDI-TOF MS than for biochemical identification. Specif-
ically, the time to identification decreased from 32.5 hours
to 4.1 hours (7.93-fold) for aerobes and from 71.5 hours to
46 hours (1.55-fold) for anaerobes. Furthermore, the cost
and waste of bacterial identification by using these two
methods was compared. MALDI-TOF MS identification
reduced the cost from US$1.6 to US$0.7 per isolate (2.29-
fold) and reduced the weight of biohazard waste from
420 kg/month to 70 kg/month (6-fold).
Impact of MALDI-TOF MS identification on clinical
outcomes
E. coli and K. pneumoniae are two commonly isolated
Gram-negative bacteria of clinical relevance in Taiwan.
To investigate the effects of using MALDI-TOF MS for rapid
bacterial identification on antimicrobial therapies and
clinical outcomes, patients positive for E. coli or K.
pneumonia identified using biochemical testing (n Z 114)
or MALDI-TOF MS (n Z 148) were compared over identicaln of microorganisms by matrix-assisted laser desorption ionization
and clinical outcome, Journal of Microbiology, Immunology and
Table 2 Routine identification performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
for yeasts and nontuberculous mycobacteria (NTM).
Microorganism Total no. No. (%) of isolates identified
to
No. (%) of unidentified isolates
Species level Genus level Total No peaks found No reliable
identification
Yeast 81 63 (77.8) 76 (93.8) 5 (6.2) 4 (4.9) 1 (1.2)
Candida glabrata 19 19 (100.0) 19 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Candida tropicalis 16 12 (75.0) 15 (93.7) 1 (6.3) 1 (6.3) 0 (0.0)
Candida albicans 15 11 (73.3) 15 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Candida parapsilosis 14 9 (64.3) 12 (85.7) 2 (14.3) 2 (14.3) 0 (0.0)
Others 17 12 (70.6) 15 (88.2) 2 (11.8) 1 (5.9) 1 (5.9)
NTM 138 104 (75.4) 125 (90.6) 13 (9.4) 6 (4.3) 7 (5.0)
Slow-growth 90 62 (68.8) 83 (92.2) 7 (7.8) 5 (5.5) 2 (2.2)
Mycobacterium chimaera
intracellulare group
30 22 (73.3) 27 (90.0) 3 (10.0) 2 (6.6) 1 (3.3)
Mycobacterium gordonae 13 9 (69.2) 13 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Mycobacterium kansasii 9 7 (77.8) 9 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Mycobacterium avium 8 5 (62.5) 7 (87.5) 1 (12.5) 1 (12.5) 0 (0.0)
Mycobacterium porcinum 6 6 (100.0) 6 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Mycobacterium intracellulare 5 3 (60) 4 (80.0) 1 (20.0) 1 (0.2) 0 (0.0)
Others 19 10 (52.6) 17 (89.5) 2 (10.5) 1 (5.3) 1 (5.3)
Rapid-growth 48 42 (87.5) 42 (87.5) 6 (12.5) 1 (2.0) 5 (10.4)
Mycobacterium fortuitum 28 26 (92.9) 26 (92.9) 2 (7.0) 0 (0.0) 2 (7.1)
Mycobacterium abscessus 14 12 (85.7) 12 (85.7) 2 (14.3) 0 (0.0) 2 (14.3)
Others 6 4 (66.7) 4 (66.7) 2 (33.3) 1 (16.7) 1 (16.7)
Table 3 Comparison of processing time, cost, and waste weight between matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry and biochemical identification.
Method Culture time (h) Time-to-
identification (h)
Average cost per
identification (US$)
Weight of biohazard
waste per month (kg)
Aerobes Anaerobes Aerobes Anaerobes
Biochemical identification 24.9 49.3 32.5 71.5 1.6 420
MALDI-TOF MS identification 23.3 45.6 4.1 46 0.7 70
Fold-reduction 1.07 1.08 7.93 1.55 2.29 6
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+ MODEL3-month periods before and after MALDI-TOF MS imple-
mentation (Table 4). No statistically significant difference
was observed between biochemical and MALDI-TOF MS
identification regarding the mean age (64.9  17.3 vs.
66.7  14.5), male-to-female ratio (41/73 vs. 51/97), and
number of hospitalization days (16.4 vs. 17.6). Imple-
menting MALDI-TOF MS shortened the time required for
selecting appropriate antibiotics for treatment from
3.3 days to 2.5 days (p < 0.05), and the percentage of
antibiotic prescriptions that matched the antibiotic sus-
ceptibility pattern increased from 56.1% to 75%
(p < 0.05). Although the mortality rate decreased from
9.6% to 6.1%, this difference did not reach statistical
significance.Discussion
Rapidly and accurately identifying microorganisms is
essential for guiding antimicrobial therapy and improvingPlease cite this article in press as: Ge M-C, et al., Routine identificatio
time-of-flight mass spectrometry: Success rate, economic analysis,
Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.06.002patient outcomes. Microbial identification is achieved
within minutes by using MALDI-TOF MS, whereas it requires
hours or days using biochemical methods. In this study,
MALDI-TOF MS successfully identified 11,712 of 12,202 (96%)
isolates from four types of microorganisms at the genus
level (score  1.7), namely 10,170 aerobes, 1341 anaer-
obes, 76 yeasts, and 125 NTM, during a 6-month study
period (Tables 1 and 2), demonstrating the use of MALDI-
TOF MS for accurately identifying microorganisms as pre-
viously described.10e14 Similar results were observed for
aerobic Gram-negative and Gram-positive bacteria at the
genus (96.7% vs. 97.2%) and species levels (89.3% vs. 87.5%),
respectively. Our data also showed that 90.5% and 78.5% of
anaerobic isolates were identified at the genus and species
levels, respectively (Table 1), which were comparable with
previous studies.15 These data indicate that MOLDI-TOF MS
is reliable in identifying aerobic and anaerobic bacteria,
although the success rates are lower for the aerobes V.
streptococcus and K. pneumonia and the anaerobes Pep-
tostreptococcus spp. and Prevotella spp.n of microorganisms by matrix-assisted laser desorption ionization
and clinical outcome, Journal of Microbiology, Immunology and
Table 4 Antibiotic treatment and patient outcomes for
matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) and biochemical
identification.
Biochemical
identification
MALDI-TOF MS
identification
Patient
No. 114 148
Age (y) 64.9  17.3 66.7  14.5
Male/female 41/73 51/97
Escherichia coli/
Klebsiella pneumonia
96/18 126/22
Outcome
Hospitalization day 16.4  9.2 17.6  9.4
Correct antibiotic
treatment
56.1%* 75%*
Time to antibiotics (d) 3.3  1.6* 2.5  0.9*
Mortality rate 9.6% 6.1%
*p < 0.05.
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+ MODELFor identifying Candida species, we used an etha-
noleformic acid extraction method, and identified < 80% of
nonglabrata Candida species isolates (Table 2). However,
previous studies showed that the identification rate signifi-
cantly increased from 65.8% to 88% by using the direct smear
method with formic acid overlay and reducing Biotyper
threshold from 2.0 to 1.7.16 Furthermore, DeCarolis et al
used an in-house library database, and 99.5% of 4232 yeast
isolates were identified at the species level (with scores of
2.0).17 For Mycobacterium identification, our results indi-
cated that theBruker system identified only 75.4%of 138NTM
isolates (Table 2). However, the Bruker system achieved
species-level identification for 87.4% of NTM isolates after
comparing with those data in an augmented database of 123
clinical Mycobacterium strains.18 To achieve acceptable
species-level identification, further research is required for
investigating analytical factors for optimal yeast and Myco-
bacterium identification in clinical laboratories, including a
fast sample preparation procedure, modification of the Bio-
typer threshold, and the development of in-house library
databases.
The advantage of using MALDI-TOF MS for microbial
identification pertains to cost. Our results showed that
MALDI-TOF MS yielded a 2.29-fold reduction in cost. The
cost saving per isolate reached US$0.9, and the total saving
per year was approximately US$94,500 (according to 47,200
aerobic and 5300 anaerobic bacteria reported in the second
half of 2012) when protein standards and instrument
maintenance were considered (Table 3). In a recent report,
Seng et al described an 11-year experience in the routine
identification of clinical isolates, including 40 months of
MALDI-TOF MS usage and 91 months of conventional
phenotypic identification. MALDI-TOF MS identified 284,899
isolates of 459 species among 286,842 clonal isolates and
reduced the cost five-fold compared with conventional
phenotypic identification (Gram staining, API, Vitek 2 sys-
tem identification), also showing that MALDI-TOF MS
significantly reduced the cost of microbial identification.19
Another benefit of MALDI-TOF MS identification isPlease cite this article in press as: Ge M-C, et al., Routine identificatio
time-of-flight mass spectrometry: Success rate, economic analysis,
Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.06.002reduction of indirect costs such as that of waste manage-
ment. Using MALDI-TOF MS can reduce waste by 350 kg/
month or 4.2 tons/year; thus, it is more environmentally
friendly than biochemical methods, which generate over
400 kg of biohazard waste/month (Table 3). A limitation of
the current study is that the results are based on data
collected for a short period, and bacteria activity is
assumed to be constant for half a year. Nevertheless, our
study demonstrated that implementing MALDI-TOF MS
reduced the laboratory cost and the number of isolates
requiring biochemical testing for identification.
In general, only a small fraction of a single colony or a
small quantity of a bacterial suspension is required for MS
identification. Therefore, an improved workflow was
developed after implementing MALDI-TOF MS. The culture
time for MS identification slightly decreased relative to that
of the biochemical method because MS identification en-
tails using a lower quantity of inoculants and requires no
prolonged incubation (Table 3). Time to identification
significantly decreased from 32.5 hours and 71.5 hours in
the biochemical method to 4.1 hours and 46 hours in MALD-
TOF MS for aerobes and anaerobes, respectively (Table 3).
Early identification increases the chances for successful
treatment. Hence, early and empirical antibiotic treatment
has been associated with a significant reduction in the
mortality of bloodstream infection.20 In this study, we
evaluated the effects of using MALDI-TOF MS for E. coli and
K. pneumonia identification on antimicrobial therapies and
clinical outcomes. The prevalence of antimicrobial resis-
tance in E. coli and K. pneumonia remains low, but has
increased in recent years in Taiwan.21 Through rapid bac-
terial identification by using MALDI-TOF MS, antibiograms
representing the typical susceptibility of identified species
can serve as a guide for empiric antimicrobial therapy. For
E. coli and K. pneumonia, MALDI-TOF MS implementation
facilitates beginning empirical antibiotic treatment earlier
(3.3 vs. 2.5 days) and increases the proportion (56.1% vs.
75%) of prescriptions matching drug-susceptibility patterns
(Table 4). A significant reduction was not observed in the
hospitalization days, although previous studies have shown
that the mean hospital stay decreased after MALDI-TOF MS
identification and rapid antimicrobial susceptibility testing
were implemented.22 Besides, MALDI-TOF MS combined
with antimicrobial stewardship team (AST) intervention has
demonstrated a significant reduction of mortality from
20.3% to 14.5% on bloodstream infection.23 Our data also
showed a reduced mortality rate (9.6% to 6.1%) after
MALDI-TOF MS implementation, but our sample size was
insufficient to detect statistical significance.
This study provides insight into the economic benefits of
MALDI-TOF MS and demonstrated its performance in iden-
tifying numerous clinical isolates, reflecting its potential to
become a major identification system in teaching hospitals.
Expanding the database by increasing numbers of reference
strains will contribute to the overall reliability of identifi-
cation. Moreover, developing a suitable protocol for some
bacteria to lyse cell walls efficiently may facilitate
obtaining high-quality spectra in the future. MALDI-TOF MS
enables rapid and reliable identification of microorganisms
and assigns a microbial cause to an infection, thus facili-
tating the provision of effective antimicrobial treatments
to improve the clinical outcome.n of microorganisms by matrix-assisted laser desorption ionization
and clinical outcome, Journal of Microbiology, Immunology and
Economic and medical analysis of MALDI-TOF MS 7
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